Description |
InvivoChem Cat #:V0151CAS #:1276553-09-3Purity >=98%Description: PF-4989216 is a novel, potent, orally bioactive and selective small molecule inhibitor of PI3K (phosphatidylinositol 3-kinase) with potential anticancer activity. It inhibits PI3K isoforms p110alpha, p110beta, p110gamma, p110delta, and VPS34 with IC50 of 2 nM, 142 nM, 65 nM, 1 nM, and 110 nM, respectively. PF-4989216 inhibited PI3K downstream signaling and subsequently led toapoptosis induction, and inhibition in cell viability, transformation, and xenograft tumor growth in SCLCs harboring PIK3CA mutation. Description: Description: PF-4989216 is a novel, potent, orally bioactive and selective small molecule inhibitor of PI3K (phosphatidylinositol 3-kinase) with potential anticancer activity. It inhibits PI3K isoforms p110alpha, p110beta, p110gamma, p110delta, and VPS34 with IC50 of 2 nM, 142 nM, 65 nM, 1 nM, and 110 nM, respectively. PF-4989216 inhibited PI3K downstream signaling and subsequently led toapoptosis induction, and inhibition in cell viability, transformation, and xenograft tumor growth in SCLCs harboring PIK3CA mutation. with IC50 of 2 nM, 142 nM, 65 nM, 1 nM, and 110 nMReferences: Clin Cancer Res. 2014 Feb 1; 20(3):631-43. References: References: |